ATOS - ATOSSA THERAPEUTICS, INC.
4.92
0.200 4.065%
Share volume: 136,363
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$4.72
0.20
0.04%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-13-2024 | 08-12-2024 | 11-12-2024 | 03-25-2025 | 05-13-2025 | 08-12-2025 | 11-12-2025 | |
| Cash flow financing | 204.000 K | 100.000 K | 0.000 | 3.369 M | 0.000 | 0.000 | 0.000 | |
| Other financing cash flows | 204.000 K | 100.000 K | 0.000 | 3.369 M | 0.000 | 0.000 | 0.000 | |
| Cash flow | -4.500 M | -4.434 M | 0.000 | 0.000 | -5.968 M | 0.000 | 0.000 | |
| Net income | -5.878 M | -6.049 M | -7.230 M | -6.347 M | -6.718 M | -8.423 M | -8.692 M | |
| Depreciation | 5.000 K | 4.000 K | 4.000 K | 4.000 K | 4.000 K | 4.000 K | 4.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -6.000 K | -3.000 K | -10.000 K | 0.000 | -9.000 K | 0.000 | -7.000 K | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 6.000 K | 3.000 K | 10.000 K | 0.000 | 9.000 K | 0.000 | 7.000 K | |
| Cash Change | -4.500 M | -4.434 M | -4.760 M | -3.682 M | -5.968 M | -7.259 M | -6.012 M |